Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 387 clinical trials in Maastricht, The Netherlands across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Anifrolumab for Adults with Active Lupus Nephritis
The NetherlandsStudy of Fulvestrant and Abemaciclib for Women with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
BelgiumStudy of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis
The NetherlandsStudy on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease
AustriaStudy on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy
AustriaStudy on Vudalimab or Pembrolizumab with Chemotherapy for Advanced Non-small Cell Lung Cancer Patients
The NetherlandsStudy of mRNA-4157 and Pembrolizumab for Patients with Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma
BelgiumStudy of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant
The NetherlandsStudy of Vitamin C (Ascorbic Acid) in Patients Undergoing Open-Heart Surgery to Reduce Post-Surgery Inflammation
GermanyStudy on Obinutuzumab and Venetoclax for Elderly Patients with Chronic Lymphocytic Leukemia Unfit for Standard Treatments
The NetherlandsStudy Comparing Inclisiran and Bempedoic Acid for Lowering LDL Cholesterol in Patients with Atherosclerotic Cardiovascular Disease
GermanyStudy of Pembrolizumab with Chemotherapy for Patients with Gastric or Gastroesophageal Junction Cancer
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, breast cancer, and melanoma treatments. Studies include novel therapy combinations and personalized treatment approaches.
Particular emphasis on targeted therapies and treatment optimization for various cancer types.
Research focusing on chronic kidney disease, fibromyalgia, and inflammatory bowel conditions. Studies evaluate new therapeutic approaches and treatment combinations.
Emphasis on developing effective long-term management strategies for chronic conditions.
Investigations into peripheral arterial disease and cardiomyopathy treatments. Research includes innovative therapeutic approaches and preventive strategies.
Focus on improving patient outcomes through targeted interventions and preventive measures.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
